Humana Inc. (NYSE:HUM) is Columbus Hill Capital Management L.P.'s 8th Largest Position

Columbus Hill Capital Management L.P. lifted its holdings in shares of Humana Inc. (NYSE:HUM - Free Report) by 36.5% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 112,622 shares of the insurance provider's stock after purchasing an additional 30,132 shares during the quarter. Humana comprises about 5.6% of Columbus Hill Capital Management L.P.'s holdings, making the stock its 8th biggest holding. Columbus Hill Capital Management L.P. owned about 0.09% of Humana worth $28,573,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in HUM. Ilmarinen Mutual Pension Insurance Co grew its stake in shares of Humana by 46.2% in the fourth quarter. Ilmarinen Mutual Pension Insurance Co now owns 9,500 shares of the insurance provider's stock worth $2,410,000 after acquiring an additional 3,000 shares in the last quarter. Russell Investments Group Ltd. grew its stake in Humana by 43.2% during the 4th quarter. Russell Investments Group Ltd. now owns 454,072 shares of the insurance provider's stock worth $115,210,000 after purchasing an additional 137,039 shares in the last quarter. Grantham Mayo Van Otterloo & Co. LLC increased its holdings in Humana by 144.5% during the 4th quarter. Grantham Mayo Van Otterloo & Co. LLC now owns 40,365 shares of the insurance provider's stock worth $10,241,000 after purchasing an additional 23,853 shares during the period. Rhenman & Partners Asset Management AB raised its position in Humana by 78.2% in the 4th quarter. Rhenman & Partners Asset Management AB now owns 55,230 shares of the insurance provider's stock valued at $14,012,000 after purchasing an additional 24,230 shares in the last quarter. Finally, Resona Asset Management Co. Ltd. purchased a new position in shares of Humana in the 4th quarter valued at about $10,117,000. Hedge funds and other institutional investors own 92.38% of the company's stock.

Remove Ads

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on HUM shares. Cantor Fitzgerald restated a "neutral" rating and set a $290.00 target price on shares of Humana in a research note on Wednesday, February 12th. Royal Bank of Canada reissued an "outperform" rating and issued a $283.00 price objective on shares of Humana in a research report on Wednesday, February 12th. Truist Financial lifted their price objective on shares of Humana from $290.00 to $325.00 and gave the stock a "hold" rating in a research report on Friday. Guggenheim initiated coverage on shares of Humana in a research note on Wednesday. They set a "buy" rating and a $326.00 target price for the company. Finally, Morgan Stanley cut their price target on Humana from $301.00 to $285.00 and set an "equal weight" rating on the stock in a research note on Wednesday, February 12th. Seventeen investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $286.00.

Humana Stock Performance

HUM traded up $2.60 during trading on Friday, hitting $292.85. The stock had a trading volume of 622,751 shares, compared to its average volume of 1,744,128. The firm has a market capitalization of $35.35 billion, a P/E ratio of 29.46, a PEG ratio of 2.05 and a beta of 0.62. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $406.46. The company's 50-day moving average price is $265.56 and its 200 day moving average price is $270.77.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. On average, equities research analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be given a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.21%. The ex-dividend date is Friday, March 28th. Humana's payout ratio is 35.58%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.